Consecutive screening and enrollment in clinical trials: The way to representative patient samples?
- 1 September 1998
- journal article
- research article
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 4 (3), 225-230
- https://doi.org/10.1016/s1071-9164(98)80009-2
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Dofetilide in patients with left ventricular dysfunction and either heart failure or acute myocardial infarction: Rationale, design, and patient characteristics of the DIAMOND studiesClinical Cardiology, 1997
- Clinical Guideline: Part II: Risk Stratification after Myocardial InfarctionAnnals of Internal Medicine, 1997
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)The Lancet, 1997
- Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIATThe Lancet, 1997
- Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIATThe Lancet, 1997
- Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarctionThe Lancet, 1996
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1995
- Who benefits from medical interventions?BMJ, 1994
- Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1992